by tlogan | Feb 16, 2022 | Press Release
Phosphorex and Dolomite Host Collabarative Webinar to Share Their Insights on Making Liposomes and Lipid Nanoparticles (LNPs) with Microfluidics Hopkinton, MA, Feburary 16, 2022 – Phosphorex & Dolomite experts Dr. Julia Rashba-Step, Dr. Cate O’Brien, Dr. Nicholas...
by tlogan | Aug 11, 2021 | Article, Press Release
Phosphorex and Dolomite Jointly Publish Articles to Discuss How Automation Benefits Development and Production of Lipid Nanoparticles (LNPs) Hopkinton, MA, August 11, 2021 – Dr. Julia Rashba-Step, Phosphorex’ Vice President of R&D and Alliance Management,...
by tlogan | Jul 27, 2021 | Press Release
Phosphorex Presents Its Nanosuspension Formulation at CRS Meeting Hopkinton, MA , July 27, 2021 – Dr. Bin Wu, Phosphorex’ President and CEO, today presented “A Novel Indirubin Nanosuspension for Potential Treatment of Glioblastoma” at the 2021 Controlled Release...
by tlogan | Jun 3, 2021 | Press Release
Phosphorex and Dolomite Microfluidics Partner to Accelerate Lipid Nanoparticle (LNP) Development Hopkinton, Mass., June 1, 2021 — Phosphorex, Inc., a leading contract development and manufacturing organization specializing in particle-based formulation of drug...
by Jenn McGroary | Jan 7, 2021 | Press Release
Phosphorex Expands Facilities HOPKINTON, Mass., January 7, 2021 — Phosphorex, Inc., a leading contract development and manufacturing organization (CDMO) specializing in long-acting formulations, nanomedicine and nucleic acid delivery, announced today the...
Recent Comments